Anhui Huangshan Capsule Co Ltd (SHE:002817) — Market Cap & Net Worth
Market Cap & Net Worth: Anhui Huangshan Capsule Co Ltd (002817)
Anhui Huangshan Capsule Co Ltd (SHE:002817) has a market capitalization of $279.24 Million (CN¥1.91 Billion) as of June 16, 2026. Listed on the SHE stock exchange, this China-based company holds position #15310 globally and #4531 in its home market, demonstrating a -5.34% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anhui Huangshan Capsule Co Ltd's stock price CN¥6.38 by its total outstanding shares 299098170 (299.10 Million). Review total liabilities of Anhui Huangshan Capsule Co Ltd to assess the company's total debt and financial obligations.
Anhui Huangshan Capsule Co Ltd Market Cap History: 2016 to 2026
Anhui Huangshan Capsule Co Ltd's market capitalization history from 2016 to 2026. Data shows growth from $683.72 Million to $279.24 Million (1.59% CAGR).
Anhui Huangshan Capsule Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Anhui Huangshan Capsule Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.73x
Anhui Huangshan Capsule Co Ltd's market cap is 0.73 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.12x
Anhui Huangshan Capsule Co Ltd's market cap is 5.12 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $683.72 Million | $283.44 Million | $52.28 Million | 2.41x | 13.08x |
| 2017 | $369.66 Million | $285.96 Million | $46.42 Million | 1.29x | 7.96x |
| 2018 | $207.81 Million | $294.71 Million | $35.97 Million | 0.71x | 5.78x |
| 2019 | $274.61 Million | $325.56 Million | $39.13 Million | 0.84x | 7.02x |
| 2020 | $274.90 Million | $319.43 Million | $45.26 Million | 0.86x | 6.07x |
| 2021 | $363.77 Million | $379.89 Million | $56.89 Million | 0.96x | 6.39x |
| 2022 | $383.46 Million | $428.32 Million | $60.85 Million | 0.90x | 6.30x |
| 2023 | $377.49 Million | $462.77 Million | $64.86 Million | 0.82x | 5.82x |
| 2024 | $273.98 Million | $473.48 Million | $49.25 Million | 0.58x | 5.56x |
| 2025 | $332.63 Million | $457.84 Million | $64.99 Million | 0.73x | 5.12x |
Competitor Companies of 002817 by Market Capitalization
Companies near Anhui Huangshan Capsule Co Ltd in the global market cap rankings as of June 16, 2026.
Key companies related to Anhui Huangshan Capsule Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #512 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #560 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #613 globally with a market cap of $44.69 Billion USD ( CN¥305.43 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #629 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #512 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #560 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.41 |
| #613 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $44.69 Billion | CN¥47.88 |
| #629 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.60 |
Anhui Huangshan Capsule Co Ltd Historical Marketcap From 2016 to 2026
Between 2016 and today, Anhui Huangshan Capsule Co Ltd's market cap moved from $683.72 Million to $ 279.24 Million, with a yearly change of 1.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥279.24 Million | -16.05% |
| 2025 | CN¥332.63 Million | +21.41% |
| 2024 | CN¥273.98 Million | -27.42% |
| 2023 | CN¥377.49 Million | -1.56% |
| 2022 | CN¥383.46 Million | +5.41% |
| 2021 | CN¥363.77 Million | +32.33% |
| 2020 | CN¥274.90 Million | +0.11% |
| 2019 | CN¥274.61 Million | +32.14% |
| 2018 | CN¥207.81 Million | -43.78% |
| 2017 | CN¥369.66 Million | -45.93% |
| 2016 | CN¥683.72 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Anhui Huangshan Capsule Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $279.24 Million USD |
| MoneyControl | $279.24 Million USD |
| MarketWatch | $279.24 Million USD |
| marketcap.company | $279.24 Million USD |
| Reuters | $279.24 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Anhui Huangshan Capsule Co Ltd
Anhui Huangshan Capsule Co., Ltd. engages in the research and development, production, and sale of gelatin and enteric-coated gelatin empty capsules in China. The company offers pullulan capsules, entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colonsoluble vacant gelatin capsules, hydroxypropyl methyl cellulose hollow capsules, and hydroxypropyl st… Read more